Angle (AGL)

 

Latest News

Issue of Equity

RNS Number: 1993K Angle PLC 19 September 2016 For immediate release 19 September 2016 ANGLE plc ("ANGLE" or "the Company") Issue of Equity ANGLE plc (AIM:AGL and OTCQX:ANPCY), the specialist medtech company, announces that it has received notice from an employee to exercise options over 22,000 ordinary shares of 10p each in the Company. Sha...

Annual Report and Accounts and Notice of AGM

RNS Number: 4753J Angle PLC 09 September 2016 For immediate release 9 September 2016 ANGLE plc ("ANGLE" or "the Company") Annual Report and Accounts and Notice of AGM ANGLE plc (AIM:AGL and OTCQX:ANPCY), the specialist medtech company, announces that its Annual Report and Accounts for the year ended 30 April 2016 and its Notice of A...

MD Anderson Cancer Center poster presentation

RNS Number: 1492G Angle PLC 04 August 2016 For immediate release 4 August 2016 ANGLE plc ("the Company") MD ANDERSON CANCER CENTER DEMONSTRATES CLINICAL APPLICABILITY OF ANGLE'S "BLOOD BIOPSY" TECHNOLOGY Poster presentation at AACC shows harvest of breast cancer cells in blood using Parsortix cell separation syste...

Edison issues ADR update on Angle

RNS Number: 0342G Angle PLC 02 August 2016 London, UK, 2 August 2016 Edison issues ADR update on Angle (ANPCY) Recent newsflow from Angle and the FY16 report released last week showed progress in developing and commercializing the liquid biopsy diagnostic system Parsortix. The R&D strategy is progressing, with the ovarian cancer trials recruiting fir...

All News

DateHeadlineSource
19-09-16Issue of EquityRNS
09-09-16Annual Report and Accounts and Notice of AGMRNS
04-08-16MD Anderson Cancer Center poster presentationRNS
02-08-16Edison issues ADR update on AngleRNS
28-07-16ANGLE revenue upStockMarketWire
28-07-16Use of Parsortix in GANNET53 drug trialRNS
28-07-16Preliminary ResultsRNS
27-07-16ANGLE initiates ovarian cancer study in the USStockMarketWire
27-07-16Initiation of 200 patient US ovarian cancer studyRNS
19-07-16ANGLE initiates European ovarian cancer study StockMarketWire
19-07-16Initiation of European ovarian cancer studyRNS
15-07-16Notice of ResultsRNS
15-07-16Parsortix gaining traction at EACR ConferenceRNS
01-06-16Holding(s) in CompanyRNS
31-05-16Holding(s) in CompanyRNS
27-05-16Edison research update on AngleStockMarketWire
27-05-16Edison issues research update on AngleRNS
25-05-16ANGLE wins contract with Cancer Research UKStockMarketWire
25-05-16Cancer Research UK ContractRNS
25-05-16PlacingRNS
29-04-16NEW PUBLICATIONS UTILISING PARSORTIXRNS
22-04-16AIM share tips 2016: the first four monthsInteractive Investor
19-04-16Edison research update on AngleStockMarketWire
19-04-16Edison issues research update on AngleRNS
18-04-16ANGLE's Parsortix potential in metastatic breast cancerStockMarketWire
18-04-16Parsortix potential in metastatic breast cancerRNS
21-03-16Are Today’s Double-Digit Rises Just The Start For Filtronic Plc, Angle plc And ReNeuron Group Plc?Motley Fool
21-03-16Edison issues research update on AngleRNS
21-03-16Parsortix potential for prostate cancer detectionRNS
09-03-16ANGLE granted European patent for ParsortixStockMarketWire
09-03-16European patent grant for ParsortixRNS
28-01-16Interim ResultsRNS
27-01-16Notice of Interim ResultsRNS
25-01-16UKE evaluation of ANGLE's Parsortix published StockMarketWire
25-01-16UKE publishes evaluation of ParsortixRNS
31-12-15AIM share tips for 2016Interactive Investor
22-12-15Completion of Geomerics TransactionRNS
15-12-15Is It Time To Buy Angle plc & Advanced Medical Solutions Group plc?Motley Fool
15-12-15ANGLE confirms Parsortix first commercial salesStockMarketWire
15-12-15Parsortix first commercial salesRNS

RSS feeds

  • Editorial news feed for LSE:AGL Editorial
  • Regulatory news feed for LSE:AGL Regulatory